How Vascepa Works to Navigate Cardiovascular Health

[Musmadar]

Vascepa is a prescription medication that contains icosapent ethyl, a highly purified ethyl ester of eicosapentaenoic acid (EPA), which is an omega-3 fatty acid derived from fish oil. It is used to treat hypertriglyceridemia, a condition characterized by elevated levels of triglycerides in the bloodstream. Elevated triglycerides are a known risk factor for cardiovascular disease.
Vascepa works by modulating lipid metabolism, specifically targeting triglyceride levels and demonstrating anti-inflammatory properties. It has been shown to reduce the risk of major cardiovascular events, such as heart attacks and strokes, as demonstrated in the REDUCE-IT clinical trial. Vascepa is prescribed to help manage cardiovascular risk in certain individuals and is often used in conjunction with other lifestyle and medical interventions. As with any medication, its use should be supervised and monitored by healthcare professionals.

 

[CoachCabo]

It's another "supplements don't work" by the FDA but....
Here's a pharmaceutical version of that supplement for Rx only at a cost of $$$$".

Marijuana is Schedule 1, "no legitimate medical application" but they have an Rx form of it.

Let us not forget that they were going to tale NAC off the market and make it Rx only.
Now they are trying to do the same with many of the peptides. Can't let those potential profits slip away.

The double talk by the FDA and the US Government astounds me.

 

[Musmadar]

It's another "supplements don't work" by the FDA but....
Here's a pharmaceutical version of that supplement for Rx only at a cost of $$$$".

Marijuana is Schedule 1, "no legitimate medical application" but they have an Rx form of it.

Let us not forget that they were going to tale NAC off the market and make it Rx only.
Now they are trying to do the same with many of the peptides. Can't let those potential profits slip away.

The double talk by the FDA and the US Government astounds me.

It's indeed a complex landscape when it comes to FDA decisions and the pharmaceutical industry. The distinction between supplements and prescription medications can be perplexing. The examples you mentioned, like marijuana and NAC, highlight the evolving perceptions and policies around certain substances. The debate over potential profits versus public access to beneficial compounds remains a challenge. It's crucial to stay informed and engage in discussions that advocate for transparency and accessibility in healthcare decisions. The delicate balance between regulation and patient empowerment continues to be a topic that warrants careful consideration and open dialogue.
That's one of the reasons why this kind of forum flourish.